Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

Autor: Anna E.C. Stoelinga, Maaike Biewenga, Joost P.H. Drenth, Xavier Verhelst, Adriaan J.P. van der Meer, Ynto S. de Boer, Gerd Bouma, Elsemieke S. de Vries, Robert C. Verdonk, Aad P. van der Berg, Johannes T. Brouwer, Thomas Vanwolleghem, Wim Lammers, Ulrich Beuers, Arantza Farina Sarasqueta, Joanne Verheij, Tania Roskams, Stijn Crobach, Maarten E. Tushuizen, Bart van Hoek, N.M. van Gerven, U. Beuers, K.J. van Erpecum, J.W. den Ouden, A. Bhalla, J.M. Vrolijk, G.H. Koek, M.M.J. Guichelaar, J.J.M. van Meyel, L.C. Baak, M. Klemt-Kropp, M.A.M.T. Verhagen, J.Ph. Kuijvenhoven, H.M. de Jonge

Publikováno v: JHEP Reports, Vol 6, Iss 7, Pp 101088- (2024)

Background & Aims: Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) can co-exist in AIH-PBC, requiring combined treatment with immunosuppression and ursodeoxycholic acid (UDCA). The Paris criteria are commonly used to identify these p

Externí odkaz: https://doaj.org/article/23f6d160421f4af7891cf542a20a6ec4

Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

Autor: van Gerven, N., van Erpecum, K., Ouden, J den, Brouwer, J., Vrolijk, J., Gevers, T.J., Drenth, J., Guichelaar, M., Bouma, G., Schreuder, T.C.M.A., van der Wouden, E.J., Baak, L.C., Stadhouders, P., Klemt-Kropp, M., Verhagen, M., Bhalla, A., Kuijvenhoven, J., Almasio, P., Alvarez, F., Andrade, R., Arikan, C., Assis, D., Bardou-Jacquet, E., Biewenga, M., Cancado, E., Cazzagon, N., Chazouillères, O., Colloredo, G., Cuarterolo, M., Dalekos, G., Debray, D., Robles-Díaz, M., Dyson, J., Efe, C., Engel, B., Ferri, S., Fontana, R., Gatselis, N., Gerussi, A., Halilbasic, E., Halliday, N., Heneghan, M., Hirschfield, G., van Hoek, B., Hørby Jørgensen, M., Indolfini, G., Iorio, R., Invernizzi, P., Jeong, S., Jones, D., Kelly, D., Kerkar, N., Lacaille, F., Lammert, C., Leggett, B., Lenzi, M., Levy, C., Liberal, R., Lleo, A., Lohse, A., Lopez, S. Ines, de Martin, E., McLin, V., Mieli-Vergani, G., Milkiewicz, P., Mohan, N., Muratori, L., Nebbia, G., van Nieuwkerk, C., Oo, Y., Ortega, A., Páres, A., Pop, T., Pratt, D., Purnak, T., Ranucci, G., Rushbrook, S., Schramm, C., Stättermayer, A., Swain, M., Tanaka, A., Taubert, R., Terrabuio, D., Terziroli, B., Trauner, M., Valentino, P., van den Brand, F., Vergani, D., Villamil, A., Wahlin, S., Ytting, H., Zachou, K., Zeniya, M., Colapietro, Francesca, Maisonneuve, Patrick, Lytvyak, Ellina, Beuers, Ulrich, Verdonk, Robert C., van der Meer, Adriaan J., van Hoek, Bart, Kuiken, Sjoerd D., Brouwer, Johannes T., Muratori, Paolo, Aghemo, Alessio, Carella, Francesco, van den Berg, Ad P., Zachou, Kalliopi, Dalekos, George N., Di Zeo-Sánchez, Daniel E., Robles, Mercedes, Andrade, Raul J., Montano-Loza, Aldo J., van den Brand, Floris F., Slooter, Charlotte D., Macedo, Guilherme, Liberal, Rodrigo, de Boer, Ynto S., Lleo, Ana

Publikováno v: In Journal of Hepatology January 2024 80(1):53-61

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar

Autor: Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Thijs J. Giezen

Publikováno v: Therapeutic Advances in Gastroenterology, Vol 16 (2023)

Background: Many patients with inflammatory bowel disease (IBD) have transitioned from an infliximab originator to a biosimilar. However, some patients retransition to the originator (i.e. stop biosimilar and reinitiate the originator). Whether this

Externí odkaz: https://doaj.org/article/77aacd70d06b45e8b69c4b191557d5ba

Prescribing errors in post - COVID-19 patients: prevalence, severity, and risk factors in patients visiting a post - COVID-19 outpatient clinic

Autor: Rashudy F. Mahomedradja, Tessa O. van den Beukel, Maaike van den Bos, Steven Wang, Kirsten A. Kalverda, Birgit I. Lissenberg-Witte, Marianne A. Kuijvenhoven, Esther J. Nossent, Majon Muller, Kim C. E. Sigaloff, Jelle Tichelaar, Michiel A. van Agtmael

Publikováno v: BMC Emergency Medicine, Vol 22, Iss 1, Pp 1-12 (2022)

Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has challenged healthcare globally. An acute increase in the number of hospitalized patients has necessitated a rigoro

Externí odkaz: https://doaj.org/article/66cb454ad6874cd78b46f6d4e85323b2